Balyasny Asset Management LLC Regenxbio Inc. Transaction History

Balyasny Asset Management LLC

$57.8 Billion
Q1 2025

A detailed history of Balyasny Asset Management LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,398,497 shares of RGNX stock, worth $11.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,398,497

Previous 1,187,102 17.81%

Holding current value

$11.9 Million

Previous $9.18 Million 8.97%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$5.92 - $8.7 $1.25 Million - $1.84 Million	211,395 Added 17.81%	1,398,497 $10 Million
Q4 2024 Feb 14, 2025	BUY	$7.23 - $11.56 $484,359 - $774,439	66,993 Added 5.98%	1,187,102 $9.18 Million
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $3.29 Million - $4.51 Million	313,394 Added 38.85%	1,120,109 $11.7 Million
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $4.37 Million - $8.18 Million	379,760 Added 88.95%	806,715 $9.44 Million
Q1 2024 May 13, 2024	BUY	$12.17 - $24.61 $2.81 Million - $5.68 Million	230,882 Added 117.75%	426,955 $9 Million
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $7.63 Million - $12.3 Million	-591,550 Reduced 75.11%	196,073 $3.52 Million
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $3.93 Million - $4.77 Million	238,677 Added 43.48%	787,623 $13 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $2.97 Million - $3.75 Million	172,646 Added 45.88%	548,946 $11 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $6.79 Million - $9.22 Million	375,427 Added 43004.24%	376,300 $7.12 Million
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $17,809 - $21,589	873 New	873 $19,000
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $4.86 Million - $7.76 Million	-152,521 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $6.07 Million - $8.57 Million	144,504 Added 1802.47%	152,521 $7.84 Million
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $2.35 Million - $3.59 Million	-57,566 Reduced 87.78%	8,017 $459,000
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $1.56 Million - $1.97 Million	-23,937 Reduced 26.74%	65,583 $4.95 Million
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $1.46 Million - $3.98 Million	-53,536 Reduced 37.42%	89,520 $6.42 Million
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $3.44 Million - $5.36 Million	143,056 New	143,056 $4.27 Million

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.4M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $369M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Regenxbio Inc. Transaction History